HomeACADEMIA
ACADEMIA

Opdivo-Induced Myasthenia Gravis Tends to Become Severe: Keio Researchers
(Aug.21.2017)

Myasthenia gravis (MG) induced by Ono Pharmaceutical’s immune checkpoint inhibitor Opdivo (nivolumab) tends to become more severe as compared to MG cases unrelated to the drug, a team of researchers at Keio University has found ...
(LOG IN FOR FULL STORY)

News Calendar